JLGF(000712)

Search documents
锦龙股份(000712) - 2025 Q1 - 季度财报
2025-04-29 08:15
Financial Performance - Total revenue for Q1 2025 was CNY 30,510,855.80, an increase of 24.83% compared to CNY 24,442,544.39 in the same period last year[4] - Net loss attributable to shareholders was CNY -95,730,970.57, a slight improvement of 5.25% from CNY -101,036,648.65 year-over-year[4] - Basic and diluted earnings per share were both CNY -0.107, reflecting a 5.31% improvement from CNY -0.113 in the same quarter last year[4] - The company experienced a comprehensive loss of -¥163,008,782.76, compared to a loss of -¥93,377,260.58 in the previous period[21] Cash Flow - Net cash flow from operating activities was CNY -195,732,829.03, a decrease of 197.55% compared to CNY 200,639,731.84 in the previous year[4] - The company reported a net cash outflow from operating activities of -¥195,732,829.03, a significant decline from a net inflow of ¥200,639,731.84 in the previous period[23] - Cash inflow from financing activities totaled $1,381,890,000.00, down from $2,183,490,000.00 year-over-year[24] - The net cash flow from financing activities was $298,887,776.81, a significant improvement from -$95,358,382.40 in the prior period[24] Assets and Liabilities - Total assets decreased by 2.79% to CNY 23,013,265,263.16 from CNY 23,672,838,143.77 at the end of the previous year[4] - Total liabilities decreased to ¥18,699,218,338.23 from ¥19,195,782,436.08, indicating a reduction in financial obligations[20] - Shareholders' equity attributable to the parent company decreased by 5.70% to CNY 2,263,223,298.24 from CNY 2,400,018,193.42[4] Investment and Financing - The company reported a significant increase of 604.17% in repurchase agreements, rising to CNY 385,732,411.60 from CNY 54,778,066.54[7] - Short-term financing payables increased by 33.15% to CNY 828,585,220.38 from CNY 622,279,873.55[7] - The company reported a total cash inflow from issuing bonds of $342,400,000.00, compared to $61,820,000.00 previously[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 87,716[12] - The largest shareholder, Dongguan New Century Science and Education Expansion Co., Ltd., holds 27.68% of shares, amounting to 248,000,000 shares, with 242,950,000 shares pledged[12] Other Financial Metrics - The company experienced a 55.60% increase in investment income, reaching CNY 146,874,939.55 compared to CNY 94,395,560.39 in the previous year[10] - Cash and cash equivalents decreased by 59.09% to CNY 74,915,589.46 from CNY 183,126,539.02 year-over-year[10] - The company has a goodwill balance of 343,456,864.17 yuan, unchanged from the previous period[18] Regulatory and Compliance - The company is undergoing a major asset restructuring to sell 20% of Dongguan Securities, pending approval from the China Securities Regulatory Commission[15] - The company did not undergo an audit for the first quarter report[25] - The new accounting standards will be first implemented starting in 2025[26]
4月28日早间重要公告一览
Xi Niu Cai Jing· 2025-04-28 05:06
Shareholding Reduction Announcements - MEI TUNG (CHINA) LIMITED plans to reduce its shareholding in Helen Zhe by up to 22.09 million shares, representing 2.12% of the total share capital after excluding repurchased shares [1] - Shandong Railway Development Fund plans to reduce its shareholding in Century Rui Er by up to 17.55 million shares, representing 3% of the total share capital [1] - Wu Baigeng plans to reduce his shareholding in Pinwo Food by up to 2.97 million shares, representing 3% of the total share capital [1] - Huayuan International Land Port Group plans to reduce its shareholding in Phoenix Shipping by up to 30.36 million shares, representing 3% of the total share capital [3] Financial Performance Reports - United Chemical reported a revenue of 535 million yuan for 2024, a year-on-year increase of 24.80%, and a net profit of 56.43 million yuan, up 66.81% [5] - Huitong Technology achieved a revenue of 662 million yuan, a year-on-year increase of 11.84%, and a net profit of 108 million yuan, up 9.30% [7] - Guangji Pharmaceutical reported a revenue of 639 million yuan, a year-on-year decrease of 13.42%, and a net loss of 295 million yuan [8] - Anshuo Information achieved a revenue of 990 million yuan, a year-on-year increase of 11.53%, and a net profit of 15.09 million yuan, up 132.78% [9] - Yifan Pharmaceutical reported a revenue of 5.16 billion yuan, a year-on-year increase of 26.84%, and a net profit of 386 million yuan, up 170.04% [10] - Hongri Pharmaceutical reported a revenue of 5.78 billion yuan, a year-on-year decrease of 5.34%, and a net profit of 21.47 million yuan, down 95.76% [11] - Zhonglan Environmental reported a revenue of 646 million yuan, a year-on-year decrease of 22.75%, and a net profit of 13.10 million yuan, down 36.12% [13] - Feilu Co. reported a revenue of 518 million yuan, a year-on-year decrease of 37.16%, and a net loss of 140 million yuan [14] - China Great Wall reported a revenue of 14.20 billion yuan, a year-on-year increase of 5.83%, and a net loss of 1.48 billion yuan [15] - Nanshan A reported a revenue of 15.45 billion yuan, a year-on-year decrease of 15.06%, and a net profit of 267 million yuan, down 83.89% [16] - Yawen Co. reported a revenue of 2.06 billion yuan, a year-on-year increase of 6.70%, and a net profit of 75 million yuan, down 24.13% [17] - Jinlong Co. reported a revenue of 663 million yuan, a year-on-year increase of 245.16%, and a net loss of 89.23 million yuan [18] - Nanshan Holdings reported a revenue of 8.40 billion yuan, a year-on-year decrease of 30.35%, and a net loss of 1.77 billion yuan [20] - Hengfeng Information reported a revenue of 227 million yuan, a year-on-year decrease of 53.07%, and a net loss of 86.80 million yuan [21] - Wantong Technology reported a revenue of 1.21 billion yuan, a year-on-year increase of 19.58%, and a net profit of 36.92 million yuan, up 147.08% [22] - Kehua Bio reported a revenue of 1.76 billion yuan, a year-on-year decrease of 27.55%, and a net loss of 641 million yuan [23] - Dongfang Tower reported a revenue of 4.20 billion yuan, a year-on-year increase of 4.79%, and a net profit of 564 million yuan, down 10.97% [24] - Yanpai Co. reported a revenue of 785 million yuan, a year-on-year increase of 8.75%, and a net profit of 42.18 million yuan, down 35.72% [25] - Yongli Co. reported a revenue of 2.24 billion yuan, a year-on-year increase of 10.69%, and a net profit of 22.30 million yuan, down 40.73% [26]
申万宏源研究所人事调整:王胜将升任所长;知名基金经理鲍无可旗下产品半月内齐增聘 | 券商基金早参
Mei Ri Jing Ji Xin Wen· 2025-04-28 01:56
Group 1 - The core point of the news is the personnel adjustment at Shenwan Hongyuan Research Institute, with Wang Sheng being promoted to the director position, indicating stability in the management team amid industry changes [1] - The adjustment reflects a trend of transformation within the brokerage industry, as multiple research institutes have undergone leadership changes in response to the recent public fund fee reduction [1] - Wang Sheng's promotion may enhance the research capabilities of Shenwan Hongyuan, positively impacting the brokerage sector and potentially boosting related stocks [1] Group 2 - The second auction of 60.3 million shares of Jinlong Co. resulted in partial successful transfers, with the actual controller's shareholding decreasing to 4.02%, but he remains the actual controller [2] - The auction's outcome indicates market recognition of Jinlong Co.'s asset value, although it is expected to have limited short-term impact on the stock price [2] - The overall market sentiment is likely to be minimally affected by this event, with a neutral impact on the financial sector [2] Group 3 - The recent appointment of fund managers for multiple products under Baowu Ke's management has drawn market attention, with four products announcing new managers within a short period [3] - The newly appointed fund managers possess extensive experience, which may enhance the quality of fund management [3] - This trend may lead to increased focus on fund manager mobility within the fund management industry [3] Group 4 - There is a noticeable divergence in the establishment of local government investment funds, with strong momentum in regions like Guangdong and Jiangsu-Zhejiang-Shanghai, while some central and western regions see a decline [4] - The introduction of direct investment funds is gaining popularity among local governments, which may improve the efficiency of fund utilization [4] - The new policies are expected to positively influence regional industrial upgrades and the financing environment for enterprises, while also necessitating attention to regional development disparities [4]
机构风向标 | 锦龙股份(000712)2024年四季度已披露前十大机构持股比例合计下跌1.06个百分点
Xin Lang Cai Jing· 2025-04-28 01:06
Group 1 - The core viewpoint of the news is that Jinlong Co., Ltd. (000712.SZ) has reported a decrease in institutional holdings, with the top ten institutional investors holding a combined 30.99% of shares, down 1.06 percentage points from the previous quarter [1] - As of April 27, 2025, a total of 43 institutional investors disclosed holdings in Jinlong Co., Ltd., amounting to 282 million shares, which represents 31.52% of the total share capital [1] Group 2 - In the public fund sector, four public funds reported a decrease in holdings compared to the previous quarter, with a total reduction of 0.54% [2] - A total of 37 new public funds were disclosed during this period, including several ETFs and index funds [2] - One foreign fund, Hong Kong Central Clearing Limited, reported a decrease in holdings, accounting for a reduction of 0.46% [2]
锦龙股份(000712) - 关于股东股份被第二次司法拍卖的进展公告
2025-04-27 08:10
证券代码:000712 证券简称:锦龙股份 公告编号:2025-30 广东锦龙发展股份有限公司 关于股东股份被第二次司法拍卖的进展公告 根据淘宝网司法拍卖网络平台发布的《网络竞价成功确认书》: 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整,没有虚假记载、误导性陈述或重大遗漏。 广东锦龙发展股份有限公司(下称"公司")于 2025 年 3 月 31 日披露了《关于股东股份被第二次司法拍卖的提示性公告》(公告编 号:2025-21),公司实际控制人杨志茂先生所持有的合计 60,300,000 股股份于 2025 年 4 月 24 日 14 时至 2025 年 4 月 25 日 14 时止在淘 宝网司法拍卖网络平台(http://sf.taobao.com)进行公开拍卖(第 二次拍卖)。 一、本次司法拍卖的竞价结果 4.因无人出价,杨志茂先生所持有的另外 30,000,000 股股份第 二次拍卖已流拍。 二、风险提示及对公司的影响 1.用户姓名宣建棋通过竞买号 Y6363 于 2025/04/25 在广东省广 州市中级人民法院于阿里拍卖平台开展的"被执行人杨志茂持有的 广东锦龙发展股份有限公司 103 ...
锦龙股份(000712) - 关于公司2024年度营业收入扣除情况表的鉴证报告
2025-04-27 08:10
广东锦龙发展股份有限公司 营业收入扣除情况表的鉴证报告 2024 年度 关于广东锦龙发展股份有限公司2024年度 营业收入扣除情况表的鉴证报告 信会师报字[2025]第ZM10027号 广东锦龙发展股份有限公司全体股东: 我们审计了广东锦龙发展股份有限公司(以下简称"锦龙股 份")2024 年度的财务报表,包括 2024 年 12 月 31 日的合并及母公司 资产负债表、2024 年度合并及母公司利润表、合并及母公司现金流量 表、合并及母公司所有者权益变动表和相关财务报表附注,并于 2025 年 4 月 25 日出具了报告号为信会师报字[2025]第 ZM10025 号的无保 留意见审计报告。 第1页 三、工作概述 在对上述财务报表执行审计的基础上,我们接受委托,对后附的 锦龙股份2024年度营业收入扣除情况表(以下简称"营业收入扣除情 况表")执行了合理保证的鉴证业务。 一、管理层的责任 锦龙股份管理层的责任是按照《深圳证券交易所股票上市规则》 和《深圳证券交易所上市公司自律监管指南第1号——业务办理》的 相关规定编制营业收入扣除情况表,确保营业收入扣除情况表真实、 准确、完整,不存在虚假记载、误导性陈述或 ...
锦龙股份(000712) - 2024年年度审计报告
2025-04-27 08:10
广东锦龙发展股份有限公司 审计报告及财务报表 二○二四年度 广东锦龙发展股份有限公司 审计报告及财务报表 (2024 年 01 月 01 日至 2024 年 12 月 31 日止) | | 目录 | 页次 | | --- | --- | --- | | 一、 | 审计报告 | 1-6 | | 二、 | 财务报表 | | | | 合并资产负债表和母公司资产负债表 | 1-4 | | | 合并利润表和母公司利润表 | 5-6 | | | 合并现金流量表和母公司现金流量表 | 7-8 | | | 合并所有者权益变动表和母公司所有者权益变动 | 9-12 | | | 表 | | | | 财务报表附注 | 1-130 | 审计报告 信会师报字[2025]第 ZM10025 号 广东锦龙发展股份有限公司全体股东: 一、 审计意见 我们审计了广东锦龙发展股份有限公司(以下简称锦龙股份)财 务报表,包括 2024 年 12 月 31 日的合并及母公司资产负债表,2024 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公 司所有者权益变动表以及相关财务报表附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准 ...
锦龙股份(000712) - 内部控制审计报告
2025-04-27 08:10
广东锦龙发展股份有限公司 内部控制审计报告 二○二四年度 内部控制审计报告 信会师报字[2025]第 ZM10024 号 广东锦龙发展股份有限公司全体股东: 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求,我们审计了广东锦龙发展股份有限公司(以下简称"锦龙股 份")2024 年 12 月 31 日的财务报告内部控制的有效性。 一、 企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定,建立健全和有效实施内部控制,并评 价其有效性是锦龙股份董事会的责任。 二、 注册会计师的责任 中国·上海 二〇二五年四月二十五日 三、 内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。 此外,由于情况的变化可能导致内部控制变得不恰当,或对控制政策 和程序遵循的程度降低,根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 信会师报字[2025]第 ZM10024 号 广东锦龙发展股份有限公司 内控审计报告 第1页 四、 财务报告内部控制审计意见 我们认为,锦龙股份于 2024 年 12 月 31 日按照《企业内部控制 ...
锦龙股份(000712) - 年度关联方资金占用专项审计报告
2025-04-27 08:10
编制汇总表并确保其真实、准确、完整是锦龙股份管理层的责任。 我们将汇总表所载信息与我们审计锦龙股份 2024 年度财务报表时所 审核的会计资料及已审计财务报表中披露的相关内容进行了核对,没 有发现在重大方面存在不一致的情况。 为了更好地理解锦龙股份 2024 年度非经营性资金占用及其他关 联资金往来情况,汇总表应当与已审计财务报表一并阅读。 信会师报字[2025]第 ZM10026 号 广东锦龙发展股份有限公司全体股东: 我们审计了广东锦龙发展股份有限公司(以下简称"锦龙股 份")2024 年度的财务报表,包括 2024 年 12 月 31 日的合并及母公司 资产负债表、2024 年度合并及母公司利润表、合并及母公司所有者 权益变动表、合并及母公司现金流量表和相关财务报表附注,并于 2025 年 4 月 25 日出具了报告号为信会师报字[2025]第 ZM10025 号的 无保留意见审计报告。 锦龙股份管理层根据中国证券监督管理委员会《上市公司监管指 引第 8 号——上市公司资金往来、对外担保的监管要求》(证监会公 告〔2022〕26 号)和《深圳证券交易所上市公司自律监管指南第 1 号——业务办理》的相关规 ...
锦龙股份(000712) - 2024年度独立董事述职报告(潘培豪)
2025-04-27 08:04
广东锦龙发展股份有限公司 2024年度独立董事述职报告 作为广东锦龙发展股份有限公司(下称"公司")的独立董事,本 人按照《公司法》、《证券法》、《上市公司独立董事管理办法》等法 律法规和《公司章程》的规定和要求,在2024年度工作中,忠实履行职 责,积极出席相关会议,认真审议独立董事专门会议和董事会各项议案, 充分发挥了独立董事及独立董事所在的各董事会专门委员会的作用。现 将2024年度本人履行独立董事职责情况汇报如下: 一、个人基本情况 潘培豪,男,48岁,法律硕士,曾任中国工商银行广州下九路支行 信贷员、团委书记,广东联合发展律师事务所律师,广东凯成律师事务 所律师,广东科德律师事务所律师;现任广东锦龙发展股份有限公司第 十届董事会独立董事,广东信耀律师事务所律师、负责人。 报告期内,本人任职符合《上市公司独立董事管理办法》第六条规 定的独立性要求,不存在影响独立性的情况。 二、年度履职概况 | (一)董事会、股东大会出席情况 | | --- | | 独立董事姓名 本报告期应参 | | 现场出席董事 | 以通讯方式参 | 委托出席董事 | 缺席董事会次 | 是否连续两次 未亲自参加董 | 出席股东大会 ...